top of page

Topic

Liver Cancer

41 Podcasts • 19 Cases • 4 Courses on BackTable

Hear how experienced physicians manage Liver Cancer on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Optimizing Liver Cancer Treatment Through Collaboration
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Vascular & Interventional

Episode # 647  •  21 May 2026

Optimizing Liver Cancer Treatment Through Collaboration

In treating hepatocellular carcinoma (HCC), the hardest question often isn’t which treatment to use, it’s who should lead, when to transition care, and how to keep every specialty aligned. In this App Exclusive episode of the BackTable Podcast, host Dr. Jon Mizrahi is joined by interventional radiologist Dr. Juan Gimenez and transplant surgeon Dr. Ari Cohen, to discuss the structure and evolution of Ochsner Health’s multidisciplinary tumor board. Through real-world cases, they illustrate how IR, hepatology, and transplant surgery collaborate to tailor treatment plans, coordinate transitions of care, and navigate follow-up challenges for complex HCC patients.

More on Liver Cancer

Loading recent podcasts…

VI

VI Episode #647

May 21, 2026

with Dr. Juan Gimenez, Dr. Ari Cohen, Dr. Jonathan Mizrahi

Optimizing Liver Cancer Treatment Through Collaboration

In treating hepatocellular carcinoma (HCC), the hardest question often isn’t which treatment to use, it’s who should...

VI

VI Episode #644

May 12, 2026

with Dr. Neil Mehta, Dr. Ari Cohen, Dr. Venkatesh Krishnasamy

Optimizing Liver Transplant Pathways & Decision-Making

A high-functioning HCC tumor board can turn complex transplant decisions into coordinated treatment plans that account...

780+ listens

Tumor Board

Tumor Board Episode #58

May 5, 2026

with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi

Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options

When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...

100+ listens

VI

VI Episode #640

May 1, 2026

with Dr. Maarten Smits, Dr. Venkatesh Krishnasamy

Hepatic Arteriography & C-Arm CT-Guided Liver Ablation

When a liver tumor is hard to see, the limits of conventional image guidance can become the limits of treatment. In...

1,400+ listens

Tumor Board

Tumor Board Episode #59

May 12, 2026

with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart

Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?

With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...

100+ listens

VI

VI Episode #642

May 7, 2026

with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy

Exploring CPN & Radiation Segmentectomy in Liver Cancer

Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...

30+ listens

VI

VI Episode #641

May 5, 2026

with Dr. Neil Mehta, Dr. Riad Salem, Dr. Tyler Sandow

Understanding BCLC Updates & Guidelines

With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their...

1,500+ listens

VI

VI Episode #639

Apr 30, 2026

with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes, Dr. Venkatesh Krishnasamy

Advancements in Ablation Techniques for Liver Tumors

Why settle for “good enough” ablation margins when today’s tools can deliver more and decrease the risk of recurrence?...

30+ listens

VI

VI Case

Apr 9, 2026

HCC: 4.8 cm HCC Lesion in Segment 7, Locoregional Therapy or Surgical Resection?

with Dr. Riad Salem, Dr. Neil Mehta and Dr. Tyler Sandow

VI

VI Case

Jan 22, 2025

HCC: 68-year Old Non-Cirrhotic Patient with an LR5 Lesion

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 67-year Old with Cirrhosis, pHTN, 10cm Lesion

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 64-year Old with Multifocal Disease: Immunotherapy? Transplant?

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: Surgical & Non-Surgical Treatments for a 60-year Old with Solitary LR5

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: Multifocal Disease in a Non-Cirrhotic Patient

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 78-year Old Male with Ruptured Lesion

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

VI

VI Case

Jan 22, 2025

HCC: 61-year Old Male with Portal Vein Involvement

with Dr. Gabriel Schnickel, Dr. Adam Burgoyne, Dr. Heather Patton, Dr. Siddharth Padia and Dr. Zach Berman

IR, Surgical & Transplant Collaboration for HCC

Tumor Board Course

2 hours, 22 lessons

Y90 Dosing & Ablation Modalities for HCC

Tumor Board Course

2 hours, 20 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page